Form 8-K - Current report:
SEC Accession No. 0001193125-26-008300
Filing Date
2026-01-09
Accepted
2026-01-09 08:00:27
Documents
11
Period of Report
2026-01-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nams-20260109.htm   iXBRL 8-K 61261
2 EX-99.1 nams-ex99_1.htm EX-99.1 48742
  Complete submission text file 0001193125-26-008300.txt   269755

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT nams-20260109.xsd EX-101.SCH 55020
13 EXTRACTED XBRL INSTANCE DOCUMENT nams-20260109_htm.xml XML 6274
Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Filer) CIK: 0001936258 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41562 | Film No.: 26521375
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)